senktide has been researched along with n-n-propyl-n-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride in 1 studies
| Studies (senktide) | Trials (senktide) | Recent Studies (post-2010) (senktide) | Studies (n-n-propyl-n-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride) | Trials (n-n-propyl-n-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride) | Recent Studies (post-2010) (n-n-propyl-n-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride) |
|---|---|---|---|---|---|
| 292 | 1 | 50 | 67 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kameyama, T; Shinkai, N; Ukai, M | 1 |
1 other study(ies) available for senktide and n-n-propyl-n-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride
| Article | Year |
|---|---|
Involvement of dopamine receptors in beneficial effects of tachykinins on scopolamine-induced impairment of alternation performance in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amnesia; Animals; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Male; Memory; Mice; Neurokinin A; Peptide Fragments; Phenethylamines; Receptors, Cholinergic; Receptors, Dopamine D1; Receptors, Dopamine D2; Scopolamine; Substance P; Sulpiride; Tachykinins | 1998 |